Scientists hunt for clues to make endometrial cancer treatment more personal
NCT ID NCT07374809
Summary
This study aims to understand why some endometrial cancer patients respond better to immunotherapy than others. Researchers will analyze tumor tissue from 50 patients with advanced or recurrent cancer to look for biological markers that predict treatment success. The goal is to help doctors personalize future treatment plans based on a patient's specific cancer biology.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DMMR CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istituto Europeo di Oncologa
Milan, Lombardy, 20141, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.